학술논문
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates
Document Type
article
Author
Nawal Al Kaabi; Abderrahim Oulhaj; Subhashini Ganesan; Farida Ismail Al Hosani; Omer Najim; Halah Ibrahim; Juan Acuna; Ahmed R. Alsuwaidi; Ashraf M. Kamour; Ashraf Alzaabi; Badreyya Ahmed Al Shehhi; Habiba Al Safar; Salah Eldin Hussein; Jehad Saleh Abdalla; Dalal Saeed Naser Al Mansoori; Ahmed Abdul Kareem Al Hammadi; Mohammed A. Amari; Ahmed Khamis Al Romaithi; Stefan Weber; Santosh Elavalli; Islam Eltantawy; Noura Khamis Alghaithi; Jumana Nafiz Al Azazi; Stephen Geoffrey Holt; Mohamed Mostafa; Rabih Halwani; Hanif Khalak; Wael Elamin; Rami Beiram; Walid Zaher
Source
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Subject
Language
English
ISSN
2041-1723
Abstract
There is limited real-world evidence for the effectiveness of the BBIBP-CorV (Sinopharm) vaccine against severe COVID-19 disease. Here, the authors use data from Abu Dhabi and estimate effectiveness at 80% against hospitalization; 86% against critical care admission and 84% against death.